Skip to main content
SpringerLink
Log in

Antineoplastics

Reactive cutaneous capillary endothelial proliferation, emergence of drug resistance and off-label use: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Yan D, et al. Addition of PD-1 antibody camrelizumab overcame resistance to trastuzumab plus chemotherapy in a HER2-positive, metastatic gallbladder cancer patient. Cancer Research 82 (Suppl.): (plus poster) abstr. 5517, No. 12, Jun 2022. Available from: URL: http://doi.org/10.1158/1538-7445.AM2022-5517 [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastics. Reactions Weekly 1921, 41 (2022). https://doi.org/10.1007/s40278-022-22035-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-22035-0

Search

Navigation